|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grunert S, Jechlinger M and Beug H:
Diverse cellular and molecular mechanisms contribute to epithelial
plasticity and metastasis. Nat Rev Mol Cell Biol. 4:657–665. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bogenrieder T and Herlyn M: Axis of evil:
Molecular mechanisms of cancer metastasis. Oncogene. 22:6524–6536.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang S, Liu Y, Li MY, Ng CSH, Yang SL,
Wang S, Zou C, Dong Y, Du J, Long X, et al: FOXP3 promotes tumor
growth and metastasis by activating Wnt/β-catenin signaling pathway
and EMT in non-small cell lung cancer. Mol Cancer. 16:1242017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choi KW and Benzer S: Rotation of
photoreceptor clusters in the developing Drosophila eye
requires the nemo gene. Cell. 78:125–136. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takada I, Mihara M, Suzawa M, Ohtake F,
Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y,
et al: A histone lysine methyltransferase activated by
non-canonical Wnt signalling suppresses PPAR-gamma transactivation.
Nat Cell Biol. 9:1273–1285. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ishitani T, Kishida S, Hyodo-Miura J, Ueno
N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J and
Matsumoto K: The TAK1-NLK mitogen-activated protein kinase cascade
functions in the Wnt-5a/Ca(2+) pathway to antagonize
Wnt/beta-catenin signaling. Mol Cell Biol. 23:131–139. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamada M, Ohnishi J, Ohkawara B, Iemura S,
Satoh K, Hyodo-Miura J, Kawachi K, Natsume T and Shibuya H: NARF,
an nemo-like kinase (NLK)-associated ring finger protein regulates
the ubiquitylation and degradation of T cell factor/lymphoid
enhancer factor (TCF/LEF). J Biol Chem. 281:20749–20760. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shaw-Hallgren G, Chmielarska Masoumi K,
Zarrizi R, Hellman U, Karlsson P, Helou K and Massoumi R:
Association of nuclear-localized Nemo-like kinase with heat-shock
protein 27 inhibits apoptosis in human breast cancer cells. PLoS
One. 9:e965062014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sa JK, Yoon Y, Kim M, Kim Y, Cho HJ, Lee
JK, Kim GS, Han S, Kim WJ, Shin YJ, et al: In vivo RNAi screen
identifies NLK as a negative regulator of mesenchymal activity in
glioblastoma. Oncotarget. 6:20145–20159. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masoumi KC, Daams R, Sime W, Siino V, Ke
H, Levander F and Massoumi R: NLK-mediated phosphorylation of HDAC1
negatively regulates Wnt signaling. Mol Biol Cell. 28:346–355.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv L, Wan C, Chen B, Li M, Liu Y, Ni T,
Yang Y, Liu Y, Cong X, Mao G and Xue Q: Nemo-like kinase (NLK)
inhibits the progression of NSCLC via negatively modulating WNT
signaling pathway. J Cell Biochem. 115:81–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (Eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhai X, Xu L, Zhang S, Zhu H, Mao G and
Huang J: High expression levels of MAGE-A9 are correlated with
unfavorable survival in lung adenocarcinoma. Oncotarget.
7:4871–4881. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang Z, Li J, Shen Q, Feng J, Liu H, Wang
W, Xu L, Shi G, Ye X, Ge M, et al: Contribution of upregulated
dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity,
metastasis and the prediction of poor prognosis in non-small cell
lung cancer (NSCLC). Int J Cancer. 140:1620–1632. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Zhu J, Yang L, Guan C, Ni R, Wang
Y, Ji L and Tian Y: Interaction with CCNH/CDK7 facilitates CtBP2
promoting esophageal squamous cell carcinoma (ESCC) metastasis via
upregulating epithelial-mesenchymal transition (EMT) progression.
Tumour Biol. 36:6701–6714. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang S, Shi W, Chen Y, Xu Z, Zhu J, Zhang
T, Huang W, Ni R, Lu C and Zhang X: Overexpression of SYF2
correlates with enhanced cell growth and poor prognosis in human
hepatocellular carcinoma. Mol Cell Biochem. 410:1–9. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xue Q, Lv L, Wan C, Chen B, Li M, Ni T,
Liu Y, Liu Y, Cong X, Zhou Y, et al: Expression and clinical role
of small glutamine-rich tetratricopeptide repeat (TPR)-containing
protein alpha (SGTA) as a novel cell cycle protein in NSCLC. J
Cancer Res Clin Oncol. 139:1539–1549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lovly CM and Carbone DP: Lung cancer in
2010: One size does not fit all. Nat Rev Clin Oncol. 8:68–70. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Emami KH, Brown LG, Pitts TE, Sun X,
Vessella RL and Corey E: Nemo-like kinase induces apoptosis and
inhibits androgen receptor signaling in prostate cancer cells.
Prostate. 69:1481–1492. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cui G, Li Z, Shao B, Zhao L, Zhou Y, Lu T,
Wang J, Shi X, Wang J, Zuo G, et al: Clinical and biological
significance of nemo-like kinase expression in glioma. J Clin
Neurosci. 18:271–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Peng C, Wu G, Wang Y, Liu R, Yang
S, He S, He F, Yuan Q, Huang Y, et al: Expression of NLK and its
potential effect in ovarian cancer chemotherapy. Int J Gynecol
Cancer. 21:1380–1387. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li M, Zhang S, Wang Z Zhang B, Wu X, Weng
H, Ding Q, Tan Z, Zhang N, Mu J, et al: Prognostic significance of
nemo-like kinase (NLK) expression in patients with gallbladder
cancer. Tumour Biol. 34:3995–4000. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lv M, Li Y, Tian X, Dai S, Sun J, Jin G
and Jiang S: Lentivirus-mediated knockdown of NLK inhibits
small-cell lung cancer growth and metastasis. Drug Des Devel Ther.
10:3737–3746. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ishitani T and Ishitani S: Nemo-like
kinase, a multifaceted cell signaling regulator. Cell Signal.
25:190–197. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
George JT, Jolly MK, Xu S, Somarelli JA
and Levine H: Survival outcomes in cancer patients predicted by a
partial EMT Gene expression scoring metric. Cancer Res.
77:6415–6428. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duhamel S, Goyette MA, Thibault MP, Filion
D, Gaboury L and Côté JF: The E3 ubiquitin ligase HectD1 suppresses
EMT and metastasis by targeting the +TIP ACF7 for degradation. Cell
Rep. 22:1016–1030. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Singh M, Yelle N, Venugopal C and Singh
SK: EMT: Mechanisms and therapeutic implications. Pharmacol Ther.
182:80–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Feng J, Zhang X, Zhu H, Wang X, Ni S and
Huang J: FoxQ1 overexpression influences poor prognosis in
non-small cell lung cancer, associates with the phenomenon of EMT.
PLoS One. 7:e399372012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lamprecht S, Kaller M, Schmidt EM, Blaj C,
Schiergens TS, Engel J, Jung A, Hermeking H, Grünewald TGP,
Kirchner T, et al: PBX3 is part of an EMT regulatory network and
indicates poor outcome in colorectal cancer. Clin Cancer Res.
24:1974–1986. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim S, Kim Y, Lee J and Chung J:
Regulation of FOXO1 by TAK1-Nemo-like kinase pathway. J Biol Chem.
285:8122–8129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ishikawa T, Shimizu D, Kito A, Ota I,
Sasaki T, Tanabe M, Yamada A, Arioka H, Shimizu S, Wakasugi J, et
al: Breast cancer manifested by hematologic disorders. J Thorac
Dis. 4:650–654. 2012.PubMed/NCBI
|
|
40
|
Yasuda J, Tsuchiya A, Yamada T, Sakamoto
M, Sekiya T and Hirohashi S: Nemo-like kinase induces apoptosis in
DLD-1 human colon cancer cells. Biochem Biophys Res Commun.
308:227–233. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xie SL, Fan S, Zhang SY, Chen WX, Li QX,
Pan GK, Zhang HQ, Wang WW, Weng B, Zhang Z, et al: SOX8 regulates
cancer stem-like properties and cisplatin-induced EMT in tongue
squamous cell carcinoma by acting on the Wnt/β-catenin pathway. Int
J Cancer. 142:1252–1265. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma F, Li W, Liu C, Li W, Yu H, Lei B, Ren
Y, Li Z, Pang D and Qian C: MiR-23a promotes TGF-β1-induced EMT and
tumor metastasis in breast cancer cells by directly targeting CDH1
and activating Wnt/β-catenin signaling. Oncotarget. 8:69538–69550.
2017.PubMed/NCBI
|
|
43
|
Hu Y, Qi MF, Xu QL, Kong XY, Cai R, Chen
QQ, Tang HY and Jiang W: Candidate tumor suppressor ZNF154
suppresses invasion and metastasis in NPC by inhibiting the EMT via
Wnt/β-catenin signalling. Oncotarget. 8:85749–85758.
2017.PubMed/NCBI
|
|
44
|
Guo YH, Wang LQ, Li B, Xu H, Yang JH,
Zheng LS, Yu P, Zhou AD, Zhang Y, Xie SJ, et al: Wnt/β-catenin
pathway transactivates microRNA-150 that promotes EMT of colorectal
cancer cells by suppressing CREB signaling. Oncotarget.
7:42513–42526. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu X, Li Z, Song Y, Wang R, Han L, Wang
Q, Jiang K, Kang C and Zhang Q: AURKA induces EMT by regulating
histone modification through Wnt/β-catenin and PI3K/Akt signaling
pathway in gastric cancer. Oncotarget. 7:33152–33164.
2016.PubMed/NCBI
|
|
46
|
Gu Y, Wang Q, Guo K, Qin W, Liao W, Wang
S, Ding Y and Lin J: TUSC3 promotes colorectal cancer progression
and epithelial-mesenchymal transition (EMT) through WNT/β-catenin
and MAPK signalling. J Pathol. 239:60–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Duan H, Yan Z, Chen W, Wu Y, Han J, Guo H
and Qiao J: TET1 inhibits EMT of ovarian cancer cells through
activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
Gynecol Oncol. 147:408–417. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liang Z, Lu L, Mao J, Li X, Qian H and Xu
W: Curcumin reversed chronic tobacco smoke exposure induced
urocystic EMT and acquisition of cancer stem cells properties via
Wnt/β-catenin. Cell Death Dis. 8:e30662017. View Article : Google Scholar : PubMed/NCBI
|
